Formulation of Chlorpheniramine maleate tablets using co-processed excipient as a filller and binder

Co-Processed Excipient (CPE) is technological innovation for tablet preparation through the direct compression method with a quick and straightforward manufacturing process.

This research aimed to formulate and evaluate tablets prepared via a spray drying method with CPE used to improve the compressibility and flowability of formulations containing chlorpheniramine maleate. The spray dried CPE containing MCC PH 101, and Kollidon® K30 was made into tablets through a direct compression method. Meanwhile, Ludipress® and Avicel® PH 102 were used as filler-binder comparators.

Order a sample

All the prepared tablet formulations were then evaluated for weight variation, hardness, friability, disintegration time, content uniformity of active ingredient, and dissolution test. The physical properties of tablets with CPE as a filler and binder produced an average weight of 151.65 ± 1.53 mg, 5.92 ± 0.38 kg of hardness, 0.06 ± 0.051% friability, 520.00 ± 2.00 seconds of disintegration time, and 99.24 ± 0.15% content uniformity of active ingredient. The comparators indicated better disintegration time than CPE, while the dissolution test showed that more than 80% (Q) of the amount of active ingredient was dissolved in 30 minutes. CPE could be successfully used to prepare tablet dosage form, and the tablets had fulfilled the standards of pharmacopoeia.

Read the article here

Article Information: Yandi Syukri, Romdhonah Romdhonah, Anisa Nur Fazzri, Rio Fandi Sholehuddin, Aris Perdana Kusuma; Journal of Pharmaceutical Sciences and Community, 2019

Read more about BASF excipients

You might also like